TOG Review (RCOG Journal)

MRCOG Part 2

Antenatal Care

Evolution in screening of Down syndrome

Key Statistics

  • 30% — DR, maternal age alone (5% FPR)
  • 60–75% — DR, 2nd-trimester biochemistry (5% FPR)
  • 90% — DR, combined 1st-trimester test (5% FPR)

Don't-miss facts

  1. Maternal age alone: 30% DR at 5% FPR

  2. Second-trimester serum biochemistry: 60–75% DR at 5% FPR

  3. First-trimester combined test (NT + biochemistry): 90% DR at 5% FPR

  4. Cell-free DNA: 99% DR at 0.1% FPR — best performing, but currently expensive

  5. Proposed feasible model: offer cfDNA contingent on first-line combined-test result, not as universal first-line test

  6. Source is abstract-level only — verify details against full TOG article before relying on this for exam depth

Screening generations at a glance

Maternal age: 30% DR / 5% FPR 2nd-tri biochemistry: 60–75% DR / 5% FPR Combined test: 90% DR / 5% FPR

cfDNA: 99% DR / 0.1% FPR

Abbreviation Key

  • DR — detection rate
  • cfDNA — cell-free DNA
  • FPR — false positive rate
  • TOG — The Obstetrician & Gynaecologist
  • NT — nuchal translucency

Source: Ashoor Al Mahri G, Nicolaides KH. Evolution in screening of Down syndrome. The Obstetrician & Gynaecologist 2019;21:51–57. doi:10.1111/tog.12534

MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).

Included with a Pass Package

  • Audio overview of this guideline
  • Practice questions drawn from it
  • AI tutor answers grounded in its text
  • Your own annotations
Start free